Search clinical trials for: Bromfenac 0.09% eyedrops

Total 2560 results

SCAI Therapeutics

Completed

Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Dry Eye Syndromes

Korea, Republic of
Università degli Studi di Brescia

Completed

NSAIDs and PGE2 Levels in Vitrectomy Patients

Vitreous Inflammation
Alcon Research

Completed

Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency

Dry Eye Syndrome | Lipid Deficiency
Melissa Toyos
Bausch & Lomb Incorporated

Completed

Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery (QD)

Inflammation | Cataract | Retinal Edema

United States
Pfizer

Completed

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Plaque Psoriasis | Atopic Dermatitis

United States, Canada, United Kingdom, Japan
Aston University

Not yet recruiting

Protecting the Eyes of Gamers With Lubricating Eyedrops (PROTEGE)

Dry Eye Syndromes | Computer Vision Syndrome
Laboratoires Thea
Samil Pharmaceutical Co., Ltd.

Completed

Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients

Allergic Conjunctivitis

Korea, Republic of
Cairo University

Unknown

Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception

Intussusception

Egypt
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Bologna; Centro Nazionale Sangue; Regione Emilia-Romagna

Unknown

Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy

Sjogren's Syndrome | Keratopathy | GVHD - Graft-Versus-Host Disease

Italy
University of Catanzaro

Unknown

Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma (LATANOPROST)

Intraocular Pressure (IOP) | Tear Break-Up Time

Italy
Chonnam National University Hospital

Completed

Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye Syndrome

Dry Eye Syndrome

Korea, Republic of
Eisai Limited

Completed

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Alcon Research

Completed

Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining

Dry Eye Syndrome
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

Dry Eye Disease

United States
Babasaheb Ambedkar Memorial Hospital

Completed

Comparison of Treatments in Diabetic Macular Edema

Diabetic Macular Edema
Innovative Medical

Completed

Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients

Cataract

United States
Azienda Socio Sanitaria Territoriale degli Spedali...
Aristotle University Of Thessaloniki

Completed

Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) (SAF-24H-IOP)

Primary Open Angle Glaucoma | Ocular Hypertension

Greece, Italy
Galderma R&D

Completed

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (CTCL)

Cutaneous T Cell Lymphoma

United States, France, Germany
Spirig Pharma Ltd.

Completed

Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions

Actinic Keratosis

Switzerland, Germany
Bucci Laser Vision Institute
Allergan

Completed

A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)

Post Operative Anterior Chamber Inflammation (Flare)

United States
Peking University Third Hospital

Recruiting

The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye

Dry Eye

China
Allergan

Completed

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)

Cutaneous T Cell Lymphoma

United States
Wills Eye

Completed

Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.

Pain | Pain, Acute | Intravitreal Injection

United States, Canada
Sun Pharmaceutical Industries Limited

Completed

Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

Keratoconjunctivitis Sicca | Dry Eye Disease

United States
Frank A. Bucci, Jr., M.D.
Allergan

Completed

A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification

Cataracts

United States
University of Zagreb

Completed

The Effect of Ocular Lubricant Eyedrops on Lid Parallel Conjunctival Folds and Other Signs and Symptoms of Dry Eye (LIPCOF)

Dry Eye Syndromes

Croatia
Eisai Inc.

Completed

Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

Chronic Plaque Psoriasis

United States
Hospital de La Luz

Unknown

Topical Bromfenac for Intraoperative Miosis and Pain Reduction

Cataract

Mexico
Toyos Clinic
Bausch & Lomb Incorporated

Completed

Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%

Inflammation | Pseudophakia
Singapore National Eye Centre

Completed

Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye

Xerophthalmia

Singapore
Bausch & Lomb Incorporated

Completed

A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease

Dry Eye Syndrome

United States
C.O.C. Farmaceutici S.r.l.

Completed

PMCF Study to Evaluate Performance and Safety of "Xanoftal Next"

Dry Eye | Allergic Conjunctivitis | Dry Eye Disease

Italy
Chonnam National University Hospital

Completed

Umbilical Cord Serum Eye Drops

Recurrent Corneal Erosion

Korea, Republic of
Cindy Hutnik
Glaucoma Research Society of Canada

Unknown

NSAID vs Steroid in Trabeculectomy Wound Management

Glaucoma
University of Milan

Completed

Management of Dry Eye Disease After Cataract Surgery With Topical Hyaluronic Acid and Gingko Biloba

Dry Eye Syndromes

Italy
Arcispedale Santa Maria Nuova-IRCCS

Completed

Bromfenac Versus Dexamethasone After Cataract Surgery (BVD)

Inflammation Eye

Italy
Aerie Pharmaceuticals

Completed

Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan

Ocular Hypertension | Open Angle Glaucoma

Japan
Utrecht Institute for Pharmaceutical Sciences

Completed

Effects of Alcohol on Simulated Driving

Alcoholism

Netherlands
AstraZeneca

Completed

Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Non-Insulin-Dependent

United States
SIFI SpA

Completed

Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects

Acanthamoeba Keratitis
Seoul National University Hospital

Recruiting

Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy

Familial Exudative Vitreoretinopathies

Korea, Republic of
Yonsei University

Completed

Effect of ADDE on Tear Interferometry

Dry Eye Syndromes | Tear

Korea, Republic of
Johns Hopkins University

Withdrawn

Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.

Cystoid Macular Edema

United States
Allergan

Completed

A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

United States
Toyos Clinic

Withdrawn

Manuka Eye Droops for Treatment of Allergy

Allergic Conjunctivitis

United States
Kyungpook National University Hospital

Completed

Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification

Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification
Aerie Pharmaceuticals

Completed

Study of AR-13324 in Patients With Elevated Intraocular Pressure

Ocular Hypertension | Open Angle Glaucoma

United States
Laboratorios Sophia S.A de C.V.

Completed

Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. (PRO-155/IV)

Ocular Inflammation | Ocular Pain | Pterygium | Post-surgical Inflammation

Mexico
Pacific University

Withdrawn

Effects of Stulln and Accommodative Training

Accommodation Disorder | Visual Fatigue

United States

3

Subscribe